Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Enzo Biochem, Inc.

Enzo Biochem, Inc. (ENZ) Stock Overview

Explore Enzo Biochem, Inc.’s financial performance, market position, analyst ratings, and future outlook.

ENZ●NYSE
HealthcareMedical - Diagnostics & Research
$0.31
$0.02(6.08%)
U.S. Market opens in 12h 46m

Enzo Biochem, Inc. (ENZ)

Meyka AI Score

Z

Key Financials

Market Cap16.4M
P/E Ratio-0.62
EPS (TTM)$-0.14
ROE-0.39%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

ENZ Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Enzo Biochem, Inc. (NYSE: ENZ) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Enzo Biochem, Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ENZ on the NYSE shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NYSE listing.

Key metrics behind Enzo Biochem, Inc.'s NYSE-traded stock include a P/E ratio of -0.62 and a market capitalization of 16.4M. Combined with our AI analysis, these give both institutional and retail investors a clear view of ENZ on the NYSE.

Price Performance (NYSE: ENZ)

1-Day Change
-42.89%
5-Day Change
-37.24%
1-Month Change
N/A
3-Month Change
-37.44%
6-Month Change
-69.83%
Year-to-Date (YTD) Change
-56.42%
1-Year Change
-71.21%
3-Year Change
-87.35%
5-Year Change
-89.22%
All-Time (Max) Change
-54.58%

Contact Information

https://www.enzo.com
212 583 0100
527 Madison Avenue, New York City, NY, 10022

Company Facts

1,250 Employees
IPO DateJun 12, 1980
CountryUS

Frequently Asked Questions